Administrative Action on Drug Pricing: Lessons and Opportunities for the Center for Medicare and Medicaid Innovation

Liu ITT, Lalani HS, Kesselheim AS - Journal of Managed Care & Specialty Pharmacy

  • Price, Value, and Access

Summary:

The Center for Medicare and Medicaid Innovation (CMMI) is a federal agency tasked with developing innovative healthcare payment and delivery models to decrease spending while maintaining or improving patient outcomes. The authors review CMMI interventions targeted to prescription drug spending and prices, identifying lessons for policymakers on the design of future payment interventions.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty

Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open

  • Price, Value, and Access